Zhejiang Medicine Co (SHSE:600216) Net Income From Continuing Operations : ¥1,326 Mil (TTM As of Mar. 2025)

View and export this data going back to 1999. Start your Free Trial

What is Zhejiang Medicine Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Zhejiang Medicine Co's net income from continuing operations for the three months ended in Mar. 2025 was ¥385 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was ¥1,326 Mil.

Zhejiang Medicine Co Net Income From Continuing Operations Historical Data

The historical data trend for Zhejiang Medicine Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Medicine Co Net Income From Continuing Operations Chart

Zhejiang Medicine Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Income From Continuing Operations

Get a 7-Day Free Trial

659.65

884.56

362.61

276.79

1,020.25

Zhejiang Medicine Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income From Continuing Operations	Get a 7-Day Free Trial															79.36	176.00	503.19	261.69	385.25

Zhejiang Medicine Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,326 Mil.

Zhejiang Medicine Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Medicine Co Ltd (SHSE:600216) » Definitions » Net Income From Continuing Operations

Traded in Other Exchanges

N/A

Address

Comprehensive Building, No. 398 Mahuan Road, 3rd Floor, Building A, Binhai New City, Shaoxing, CHN, 312366

Website

http://www.china-zmc.com

Zhejiang Medicine Co Ltd is a china-based pharmaceutical company. The company manufactures fat-soluble vitamins, vitamins, quinolones, and antibiotic-resistant antibiotics, vitamin E, natural vitamin E, beta-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin.

Executives

Zhu Jin Lin	senior management
Chu Zhen Hua	Director
Liang Bi Rong	Director
Yu Yu Qing	Director
Ping Jian Hong	senior management
An Yong Bin	senior management
Wang Xiao Ping	senior management
Liang Li Ping	senior management
Li Qi Rong	senior management
Zhu Shao Ming	Supervisors
Wang Hong Wei	senior management
Zhang Ding Feng	senior management
Ma Wen Xin	Director
Zhao Jun Xing	senior management
Lv Yong Hui	Director

Zhejiang Medicine Co Headlines

No Headlines